Previous close | 138.01 |
Open | 132.48 |
Bid | 126.70 x 300 |
Ask | 127.20 x 100 |
Day's range | 126.75 - 138.80 |
52-week range | 74.75 - 142.00 |
Volume | |
Avg. volume | 3,087,224 |
Market cap | 50.232B |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | 97.57 |
EPS (TTM) | 1.30 |
Earnings date | 25 Jul 2024 - 29 Jul 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 151.32 |
Dexcom stock plunged Friday after the company raised its sales outlook for the year, but not enough to satisfy investors.
DexCom's (DXCM) first-quarter 2024 results reflect strong domestic and international revenue growth on the back of its real-time Continuous Glucose Monitoring system.